Icon Plc

ICLR XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

13B

Short interest (Jul 15)

3.4%

Net Short (Jul 27 ): -0.1%

Borrow Fee

0.25%

↓ 31.2%

Available Shares

800K

↓ 4.7%

Price Chart

Company Overview

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Company Info

Exchange: NASDAQ

CIK: 0001060955

Asset Type: CS

Market Data

Market Cap: $12,787,617,857

Employees: 40,100

Status: Active

Short Interest

Current Borrow Fee 0.25%

Range: 0.25% - 0.25%

Available Shares 800K

Range: 650K - 750K

Recent Changes

Fee Change: ↓ 24.0%

Available Change: ↑ 20.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime